Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
- 31 October 2006
- Vol. 39 (4) , 872-879
- https://doi.org/10.1016/j.bone.2006.04.028
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004
- Tensile yield in compact bone is determined by strain, post-yield behaviour by mineral contentJournal of Biomechanics, 2003
- Risedronate Preserves Bone Architecture in Early Postmenopausal Women In 1 Year as Measured by Three-Dimensional Microcomputed TomographyCalcified Tissue International, 2003
- Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog VertebraJournal of Bone and Mineral Research, 2003
- Stiff and strong compressive properties are associated with brittle post‐yield behavior in equine compact bone materialJournal of Orthopaedic Research, 2002
- Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beaglesBone, 2001
- Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic womenBone, 2000
- How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?Bone, 2000
- Bisphosphonates: mechanisms of action.Journal of Clinical Investigation, 1996
- The effects of ageing and changes in mineral content in degrading the toughness of human femoraJournal of Biomechanics, 1996